ENSG - NASDAQ
The Ensign Group, Inc.
$166.68
+0.41%The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
At a Glance
Live Snapshotensg
Accounts Receivables
Last Annual Value
636.99M
3-Year CAGR
16%
5-Year CAGR
16%
10-Year CAGR
12%
The Ensign Group, Inc. Competitors Analysis of Accounts Receivables
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
The Ensign Group, Inc. NASDAQ:ENSG | 636.99M | 9.5% | 14.1% | 10.1% | |
 Revvity, Inc. NYSE:RVTY | 744.67M | 5.6% | 1.0% | 5.8% | |
 Qiagen N.V. NYSE:QGEN | 402.61M | 1.8% | 2.1% | 3.8% | |
 Elanco Animal Health Incorporated NYSE:ELAN | 940.00M | 3.7% | 2.4% | 4.9% | |
 DaVita Inc. NYSE:DVA | 2.41B | 6.7% | 4.3% | 4.8% | |
 Encompass Health Corporation NYSE:EHC | 619.20M | 0.4% | 4.3% | 3.4% | |
 Universal Health Services, Inc. NYSE:UHS | 2.60B | 5.2% | 8.3% | 6.1% | |
 Align Technology, Inc. NASDAQ:ALGN | 1.10B | 6.8% | 4.2% | 16.1% | |
 BioMarin Pharmaceutical Inc. NASDAQ:BMRN | 908.21M | 12.7% | 19.5% | 15.5% | |
 Exelixis, Inc. NASDAQ:EXEL | 286.92M | 6.5% | 0.3% | 21.6% | |
 Solventum Corporation NYSE:SOLV | 1.03B | -7.7% | -2.6% | N/A |
The Ensign Group, Inc. Fair Value Envelope
Related Guides
Continue your ENSG research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.